| Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975) |
|---|
| 02/15/2011 | US7888331 Ganglioside compositions and methods of use |
| 02/15/2011 | US7887833 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting |
| 02/10/2011 | WO2011016558A1 Method for producing glucosylceramide-containing material |
| 02/10/2011 | US20110034405 Novel aminoglycoside antibiotics, process for producing the same, and pharmaceutical use thereof |
| 02/10/2011 | US20110034402 C-aryl glycoside compounds for the treatment of diabetes and obesity |
| 02/10/2011 | US20110033485 Analogues of glycolipids useful as immunoadjuvants |
| 02/09/2011 | EP2280987A2 Triterpene saponins, methods of synthesis, and uses thereof |
| 02/09/2011 | EP2280986A2 Synthetic analogues of phosphatidyl-myo-inositol mannosides with an inhibitory activity on the inflammatory response |
| 02/09/2011 | EP2280983A2 C-aryl glycoside compounds for the treatment of diabetes and obesity |
| 02/09/2011 | CN101970460A Functional lipid constructs |
| 02/09/2011 | CN101970450A Rebaudioside a derivative products and methods for making |
| 02/09/2011 | CN101967177A Extract and method for extracting tea saponin from oil-tea seed residue |
| 02/09/2011 | CN101967175A Ultrasonic wave-microwave synergetic extraction method for aescine |
| 02/09/2011 | CN101967169A 9-(4-beta-D- allopyranosyloxy-phenyl)-decahydroacridine-1,8-diketone as well as preparation method and application thereof |
| 02/09/2011 | CN101967168A Triterpenoid saponin derivative and preparation method and application thereof |
| 02/09/2011 | CN101328198B Extraction and separation method of syringin |
| 02/08/2011 | CA2559808C Spermicidal and virucidal properties of various forms of sophorolipids |
| 02/03/2011 | US20110028702 Compositions and processes for preparing 13-deoxy-anthracyclines |
| 02/03/2011 | US20110028414 Glucopyranoside derivatives |
| 02/03/2011 | US20110028411 Alpha-galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them |
| 02/03/2011 | US20110024292 Compositions and methods for cyclofructans as separation agents |
| 02/02/2011 | EP2279249A1 Saccharide structures and methods of making and using such structures |
| 02/02/2011 | CN101962396A Method for preparing tea saponin from oil tea cakes, tea seed meal, tea seed oil cakes |
| 02/02/2011 | CN101962395A Nyasicoside preparation method |
| 02/02/2011 | CN101962236A Process for recovering streptomycin sulphate from waste water by coupling foam separation and ion exchange |
| 02/02/2011 | CN101508709B Method for auxiliary extraction of aloin with mechanical force |
| 02/02/2011 | CN101139374B Method for extracting validamycin |
| 02/01/2011 | US7879808 Lincomycin derivatives and antimicrobial agents comprising the same as active ingredient |
| 02/01/2011 | US7879347 skin cosmetics for inducing lipolytic activity; reform obese constitution by promoting shrinkage of general or topical fatty tissues, prevents swelling; odor and taste free; chewing gums |
| 02/01/2011 | US7879335 Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof |
| 02/01/2011 | CA2442917C Combination therapy comprising glucose reabsorption inhibitors and ppar modulators |
| 01/27/2011 | US20110023192 Novel stevia variety and method of producing sweetener |
| 01/27/2011 | US20110021765 Fluorinated lanthanide probes for 19f magnetic resonance applications |
| 01/27/2011 | US20110021452 Lyophilized preparation of stabilized anthracycline compounds |
| 01/27/2011 | US20110021448 Inhibitors for the Soluble Epoxide Hydrolase |
| 01/26/2011 | EP2277898A2 Rapamycin analogues |
| 01/26/2011 | EP2277884A1 Anthracycline antibiotic derivatives with high activity, preparation methods and uses thereof |
| 01/26/2011 | EP2276853A2 Electrochemical labels derived from siderophores |
| 01/26/2011 | EP2276773A2 Compounds with glycidic structure active in the therapy of systemic and local inflammation |
| 01/26/2011 | CN101955501A Method for extracting and separating high-purity salidroside in pilot scale |
| 01/26/2011 | CN101357932B Separation method of salidroside and impurity therein and RP-HPLC analytical method of salidroside and impurity therein |
| 01/25/2011 | US7875708 Sialic acid derivatives |
| 01/25/2011 | US7875707 combinatorial libraries; lipid solubility; solid phase synthesis |
| 01/25/2011 | US7875592 Sulfated oligosaccharide derivatives |
| 01/25/2011 | CA2520902C Novel nitrile glycoside useful as a bio-enhancer of drugs and nutrients, process of its isolation from moringa oleifera. |
| 01/20/2011 | WO2011006237A1 2,3-fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals |
| 01/20/2011 | WO2010132839A3 Aminoglycoside dosing regimens |
| 01/20/2011 | WO2010132777A3 Treatment of urinary tract infections with antibacterial aminoglycoside compounds |
| 01/20/2011 | WO2010018438A3 Tetrazole glycosides |
| 01/20/2011 | US20110015344 Biodegradable polyacetals for in vivo polynucleotide delivery |
| 01/20/2011 | US20110014284 Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof |
| 01/20/2011 | US20110014273 Method of Treating BCC |
| 01/20/2011 | CA2767453A1 2,3-fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals |
| 01/19/2011 | CN101948491A Preparation method of polyol glucoside |
| 01/19/2011 | CN101289480B Method for separating and preparing liquiritin |
| 01/18/2011 | US7871982 potent activity against resistant pneumococci |
| 01/18/2011 | US7871765 Composition having antitumor effect |
| 01/13/2011 | WO2011003876A1 New antiviral compounds useful for the treatment or the prevention of epidemic keratoconjonctivitis |
| 01/13/2011 | US20110009352 Restorative agent for antibacterial peptide production ability |
| 01/13/2011 | CA2765919A1 New antiviral compounds useful for the treatment or the prevention of epidemic keratoconjonctivitis |
| 01/12/2011 | EP2272855A2 Production of l-iduronate containing polysaccharides |
| 01/12/2011 | EP2272854A1 Novel glycolipid and use thereof |
| 01/12/2011 | CN101945884A Agent for preventing or ameliorating skin aging |
| 01/12/2011 | CN101942495A Method for preparing ultrahigh-purity crystalline maltitol |
| 01/12/2011 | CN101942355A Comprehensive extraction method for extracting tea seed oil, tea saponin and tea seed polysaccharide from tea seeds or camellia seeds |
| 01/12/2011 | CN101941997A Stevia rebaudiana Bertoni extract and extraction method thereof and extraction method of rebaudioside A |
| 01/12/2011 | CN101941996A Ursolic acid saponin, preparation method thereof and application in resisting highly pathogenic H5N1 influenza virus |
| 01/12/2011 | CN101940579A Process for extracting and separating Angoroside C from radix scrophulariae and novel medical application of Angoroside C |
| 01/12/2011 | CN101177440B Method for rapid purification of codonopsis pilosula lobetyolin monomer from codonopsis pilosula medicinal materials |
| 01/12/2011 | CN101130560B Method for preparing rose cut flower flavouring agent |
| 01/11/2011 | US7868147 Fluorescent probe |
| 01/11/2011 | US7867980 Lincosamide derivatives and antimicrobial agents comprising the same as active ingredient |
| 01/11/2011 | CA2489912C Production method of crystalline maltitol |
| 01/11/2011 | CA2429781C Linkable sialyl lewis x analogs |
| 01/06/2011 | WO2011000721A1 Inhibitors of microbial infections |
| 01/06/2011 | US20110003981 Process for producing radioactive fluorine labeled organic compound, and relevant synthetic apparatus and program |
| 01/06/2011 | US20110002983 Compound |
| 01/06/2011 | US20110002875 Method for treating amyloidosis |
| 01/05/2011 | EP2268647A2 Compounds and compositions for the detection and treatment of alzheimer's disease and related disorders |
| 01/05/2011 | EP1488796B1 Chromanol glucosides for ameliorating cancer chemotherapy |
| 01/05/2011 | CN101935331A Novel 4,5-pyrazoline ring-containing helicid medicament with sedative activity and preparation method thereof |
| 01/05/2011 | CN101314610B Method for canalization preparation of N-butyl-beta-D-glucopyranose amine |
| 01/05/2011 | CN101195646B Production method of stilbene glycoside extract |
| 01/04/2011 | US7863428 Fluorogenic enzyme substrates and methods of preparation |
| 01/04/2011 | CA2543722C Tocopherol-modified therapeutic drug compounds |
| 01/04/2011 | CA2500190C Linker compound, ligand, and producing method thereof |
| 01/04/2011 | CA2340174C Compositions of cpg and saponin adjuvants and methods thereof |
| 12/30/2010 | US20100331272 Agent for Preventing or Ameliorating Skin Aging |
| 12/30/2010 | US20100331268 Nitrated Lipids and Methods of Making and Using Thereof |
| 12/29/2010 | WO2010149326A1 Acid-labile trigger units |
| 12/29/2010 | EP2266964A1 Acid-labile trigger units |
| 12/29/2010 | EP2266580A1 Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders |
| 12/29/2010 | CN101928325A Method for preparing natural 18-alpha glycyrrhizinic acid |
| 12/29/2010 | CN101928324A Potassium glycyrrhizinate preparation method |
| 12/29/2010 | CN101928312A Preparation method of 1-N-ethyl gentamicin C1a sulfate |
| 12/29/2010 | CN101928311A Preparation method of 1-N-ethyl gentamicin Cla |
| 12/29/2010 | CN101928310A Method for preparing 3,2',6'-tri-N-acetyl gentamicin C1a |
| 12/29/2010 | CN101928309A Synthesis method of 3,2',6'-tri-N-acetyl gentamicin Cla |
| 12/29/2010 | CN101928308A Method for preparing salidroside by using RsTyrDC |
| 12/29/2010 | CN101928307A Crystallization method of clindamycin phosphate |